CA2387231A1 - Proteines humaines de la famille des galanines et polynucleotides codant pour de telles proteines - Google Patents

Proteines humaines de la famille des galanines et polynucleotides codant pour de telles proteines Download PDF

Info

Publication number
CA2387231A1
CA2387231A1 CA002387231A CA2387231A CA2387231A1 CA 2387231 A1 CA2387231 A1 CA 2387231A1 CA 002387231 A CA002387231 A CA 002387231A CA 2387231 A CA2387231 A CA 2387231A CA 2387231 A1 CA2387231 A1 CA 2387231A1
Authority
CA
Canada
Prior art keywords
nhp
sequence
sequences
antibodies
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002387231A
Other languages
English (en)
Inventor
C. Alexander Turner Jr.
Gregory Donoho
Xiaoming Wang
Erin Hilbun
Brian Zambrowicz
Arthur T. Sands
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lexicon Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2387231A1 publication Critical patent/CA2387231A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Psychology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouveaux polypeptides humains et des séquences polypeptidiques utilisables à des fins thérapeutiques, diagnostiques, et dans des applications pharmacogénomiques.
CA002387231A 1999-10-12 2000-10-10 Proteines humaines de la famille des galanines et polynucleotides codant pour de telles proteines Abandoned CA2387231A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15884899P 1999-10-12 1999-10-12
US60/158,848 1999-10-12
PCT/US2000/027922 WO2001027273A1 (fr) 1999-10-12 2000-10-10 Proteines humaines de la famille des galanines et polynucleotides codant pour de telles proteines

Publications (1)

Publication Number Publication Date
CA2387231A1 true CA2387231A1 (fr) 2001-04-19

Family

ID=22569981

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002387231A Abandoned CA2387231A1 (fr) 1999-10-12 2000-10-10 Proteines humaines de la famille des galanines et polynucleotides codant pour de telles proteines

Country Status (5)

Country Link
EP (1) EP1232259A1 (fr)
JP (1) JP2003511073A (fr)
AU (1) AU7876700A (fr)
CA (1) CA2387231A1 (fr)
WO (1) WO2001027273A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7173112B2 (en) 2001-09-26 2007-02-06 Takeda Pharmaceutical Company Limited Antibody to GALP and uses thereof
WO2006047302A1 (fr) 2004-10-21 2006-05-04 Transtech Pharma, Inc. Composes bissulfonamide utilises en tant qu'agonistes du galr1, compositions, et procedes d'utilisation associes
EP2046825A1 (fr) * 2006-07-11 2009-04-15 Austria Wirtschaftsservice Gesellschaft mbH Peptide antimicrobien dérivé du peptide associé au message de la galanine (gmap)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7064181B1 (en) * 1998-03-25 2006-06-20 Takeda Pharmaceutical Company Limited Physiologically active peptide and its use

Also Published As

Publication number Publication date
AU7876700A (en) 2001-04-23
JP2003511073A (ja) 2003-03-25
WO2001027273A1 (fr) 2001-04-19
EP1232259A1 (fr) 2002-08-21

Similar Documents

Publication Publication Date Title
CA2359747A1 (fr) Proteines humaines bruleuses de graisses excedentaires et polynucleotides les codant
EP1220932B1 (fr) Carboxypeptidases humaines et polynucleotides codant ces dernieres
EP1244698A2 (fr) Nouvelles proteines humaines transporteuses et polynucleotides codant pour ces memes proteines
US6586582B2 (en) Human GABA receptor proteins and polynucleotides encoding the same
CA2386767A1 (fr) Nouvelles proteines du type inhibiteur de protease et polynucleotides codant pour ces proteines
CA2389600A1 (fr) Nouvelles proteines humaines du type melastatin et polynucleotides codant ces proteines
US6716616B1 (en) Human kinase proteins and polynucleotides encoding the same
CA2387231A1 (fr) Proteines humaines de la famille des galanines et polynucleotides codant pour de telles proteines
CA2390650A1 (fr) Nouvelles proteases humaines et polynucleotides les codant
US6900046B2 (en) Human ATPase proteins and polynucleotides encoding the same
US20020076780A1 (en) Novel human ion channel proteins and polynucleotides encoding the same
CA2393332A1 (fr) Nouvelles proteines de kinase de l'homme et polynucleotides codant ces dernieres
EP1632575B1 (fr) Carboxypeptidases humaines et polynucléotides les codant
US20020045743A1 (en) Novel human membrane proteins and polynucleotides encoding the same
US20050170389A1 (en) Novel human notch ligand proteins and polynucleotides encoding the same
US20060122380A1 (en) Novel human secreted proteins and polynucleotides encoding the same
CA2386213A1 (fr) Proteines de kinase de l'homme et polynucleotides codant ces dernieres
WO2001034804A1 (fr) Proteines membranaires humaines et polynucleotides codant pour elles
CA2385813A1 (fr) Nouvelles proteines humaines du type enzyme de conversion de l'endotheline et polynucleotides les codant
CA2385880A1 (fr) Proteines humaines du type transporteur d'anions organiques et polynucleotides codant ces proteines
CA2390402A1 (fr) Nouvelle proteine kinase humaine et polynucleotides codant pour cette proteine
EP1484408A1 (fr) Proteines de kinase de l'homme et polynucleotides codant ces dernieres

Legal Events

Date Code Title Description
FZDE Dead